Butler John P.
Known title: CEO and PresidentCIK: 0001591467
Butler John P.'s purchase track record
Butler John P. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/4/2026 | AKBA | $87K | -22.4% | -21.6% | +11.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| AKBA | ▲ Buy | Option Exercise | 350,000 | $221K | 8/6/2026 | View on chart |
| AKBA | ▲ Buy | Open Market | 69,270 | $87K | 3/4/2026 | View on chart |
| AKBA | ▼ Sell | Open Market | 96,065 | $134K | 2/2/2026 | View on chart |
| AKBA | ▼ Sell | Open Market | 114,891 | $160K | 2/2/2026 | View on chart |
| AKBA | ▼ Sell | Open Market | 83,689 | $116K | 2/2/2026 | View on chart |
| AKBA | ▲ Buy | Grant | 175,250 | $247K | 2/2/2026 | View on chart |
| AKBA | ▼ Sell | Open Market | 46,660 | $65K | 2/2/2026 | View on chart |
| AKBA | ▲ Buy | Grant | 743,000 | $0 | 1/30/2026 | View on chart |
| AKBA | ▼ Sell | Open Market | 46,409 | $85K | 3/3/2025 | View on chart |
| AKBA | ▼ Sell | Open Market | 46,268 | $97K | 2/3/2025 | View on chart |
| AKBA | ▼ Sell | Open Market | 97,982 | $206K | 2/3/2025 | View on chart |
| AKBA | ▲ Buy | Grant | 701,000 | $0 | 1/31/2025 | View on chart |
| AKBA | ▼ Sell | Open Market | 46,570 | $74K | 2/29/2024 | View on chart |
| AKBA | ▼ Sell | Open Market | 37,733 | $57K | 2/27/2024 | View on chart |
| AKBA | ▼ Sell | Open Market | 46,489 | $78K | 2/1/2024 | View on chart |
| AKBA | ▲ Buy | Grant | 603,500 | $0 | 1/31/2024 | View on chart |
| AKBA | ▼ Sell | Open Market | 47,239 | $41K | 3/1/2023 | View on chart |
| AKBA | ▼ Sell | Open Market | 6,370 | $6K | 3/1/2023 | View on chart |
| AKBA | ▼ Sell | Open Market | 38,259 | $34K | 3/1/2023 | View on chart |
| AKBA | ▼ Sell | Open Market | 38,632 | $31K | 2/27/2023 | View on chart |
| AKBA | ▲ Buy | Grant | 293,125 | $0 | 1/31/2023 | View on chart |
| AKBA | ▼ Sell | Open Market | 25,031 | $54K | 3/1/2022 | View on chart |
| AKBA | ▼ Sell | Open Market | 24,811 | $54K | 3/1/2022 | View on chart |
| AKBA | ▼ Sell | Open Market | 4,131 | $9K | 3/1/2022 | View on chart |
| AKBA | ▼ Sell | Open Market | 25,053 | $54K | 2/28/2022 | View on chart |
| AKBA | ▲ Buy | Grant | 293,125 | $0 | 2/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
AKBA sees no direct news updates this week
In the past week, there were no company‑specific announcements for Akebia Therapeutics (AKBA). The only notable filing was SCYNEXIS appointing Dr. Steven K. Burke to its board, which does not involve AKBA. As a result, there is little new information to affect AKBA’s market perception at this time.
AKBA sees no direct news updates this week. In the past week, there were no company‑specific announcements for Akebia Therapeutics (AKBA). The only notable filing was SCYNEXIS appointing Dr. Steven K. Burke to its board, which does not involve AKBA. As a result, there is little new information to affect AKBA’s market perception at this time.